{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:44:49Z","timestamp":1790786689602,"version":"4.1.0"},"reference-count":32,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"College of Medicine, Mohammed Bin Rashid University of Medicine, and Health Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age. It increases the risk of type 2 diabetes, cardiovascular disease, endometrial cancer, infertility, gestational diabetes, preeclampsia, and preterm birth. Accurately identifying predictors of these health risks is crucial. Electronic health records (EHRs) offer an affordable approach, however, the validity and reliability of EHRs for PCOS diagnosis are unclear. A scoping review of the literature on the prevalence and reliability of the diagnosis of PCOS using EHRs was performed. An analysis of the feasibility of obtaining diagnostic variables from a PCOS patient database was also carried out. Eight studies met the criteria. The prevalence of PCOS ranged from 0.27% to 5.8%. Reliability varied, with one study reporting a sensitivity of 50% and a specificity of 29%. Another study found a 74.4% agreement between international classification of disease (ICD) codes and clinical criteria. The database analysis found only 13.7%, 8%, and 7.5% of women had all the necessary variables for an objective diagnosis of PCOS using the Rotterdam, National Institutes of Health (NIH), and Androgen Excess and PCOS Society (AEPCOS) criteria, respectively. Using EHRs results in an underestimation of PCOS prevalence compared to other diagnostic criteria, and many women identified may not meet the complete diagnostic criteria. These findings have implications for future research studies on PCOS prevalence and related health risks.<\/jats:p>","DOI":"10.3390\/ijerph21030354","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T14:05:25Z","timestamp":1710511525000},"page":"354","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence and Diagnosis of PCOS Using Electronic Health Records: A Scoping Review and a Database Analysis"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-3504","authenticated-orcid":false,"given":"William","family":"Atiomo","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, Dubai P.O. Box 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Nor Haq","family":"Rizwan","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, Dubai P.O. Box 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hamza","family":"Bajwa","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, Dubai P.O. Box 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain Juzer","family":"Furniturewala","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, Dubai P.O. Box 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal Sundeep","family":"Hazari","sequence":"additional","affiliation":[{"name":"Latifa Women and Children Hospital, Dubai P.O. Box 9115, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-1843","authenticated-orcid":false,"given":"Deemah","family":"Harab","sequence":"additional","affiliation":[{"name":"Latifa Women and Children Hospital, Dubai P.O. Box 9115, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Widad","family":"Abdelkareem","sequence":"additional","affiliation":[{"name":"Latifa Women and Children Hospital, Dubai P.O. Box 9115, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumayya","family":"Inuwa","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, Dubai P.O. Box 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar Hassan","family":"Khamis","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, Dubai P.O. Box 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Tahlak","sequence":"additional","affiliation":[{"name":"Latifa Women and Children Hospital, Dubai P.O. Box 9115, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi G.","family":"Mirza","sequence":"additional","affiliation":[{"name":"Latifa Women and Children Hospital, Dubai P.O. Box 9115, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review","volume":"13","author":"Deswal","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the Association between Endometrial Cancer and Polycystic Ovary Syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mirza, F.G., Tahlak, M.A., Rjeili, R.B., Hazari, K., Ennab, F., Hodgman, C., Khamis, A.H., and Atiomo, W. (2022). Polycystic Ovarian Syndrome (PCOS): Does the Challenge End at Conception?. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192214914"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS). Hum. Reprod., 19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0041-1735259","article-title":"The Need to Reassess the Diagnosis of Polycystic Ovary Syndrome (PCOS): A Review of Diagnostic Recommendations from the International Evidence-Based Guideline for the Assessment and Management of PCOS","volume":"39","author":"Kiconco","year":"2021","journal-title":"Semin. Reprod. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1163771","DOI":"10.3389\/fendo.2023.1163771","article-title":"Effects of Distinct Polycystic Ovary Syndrome Phenotypes on Bone Health","volume":"14","author":"Mills","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3174\/ajnr.A4696","article-title":"ICD-10: History and Context","volume":"37","author":"Hirsch","year":"2016","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpag.2013.03.007","article-title":"Differences in the Management of Adolescents with Polycystic Ovary Syndrome across Pediatric Specialties","volume":"26","author":"Auble","year":"2013","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fertnstert.2013.04.001","article-title":"Prevalence of Polycystic Ovary Syndrome in Adolescents","volume":"100","author":"Christensen","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Castro, V., Shen, Y., Yu, S., Finan, S., Pau, C.T., Gainer, V., Keefe, C.C., Savova, G., Murphy, S.N., and Cai, T. (2015). Identification of Subjects with Polycystic Ovary Syndrome Using Electronic Health Records. Reprod. Biol. Endocrinol., 13.","DOI":"10.1186\/s12958-015-0115-z"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e23934","DOI":"10.2196\/23934","article-title":"Electronic Medical Record-Based Case Phenotyping for the Charlson Conditions: Scoping Review","volume":"9","author":"Lee","year":"2021","journal-title":"JMIR Med. Inform."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/08850666231192371","article-title":"Accuracy of International Classification of Disease Coding Methods to Estimate Sepsis Epidemiology: A Scoping Review","volume":"39","author":"Kumar","year":"2024","journal-title":"J. Intensive Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping Studies: Towards a Methodological Framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mirza, F.G., Tahlak, M.A., Hazari, K., Khamis, A.H., and Atiomo, W. (2023). Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women\u2019s Hospital in Dubai, United Arab Emirates. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20095717"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/clinem\/dgaa675","article-title":"Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records","volume":"106","author":"Actkins","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"299.e1","DOI":"10.1016\/j.ajog.2012.07.023","article-title":"Prevalence of Polycystic Ovary Syndrome among the Privately Insured, United States, 2003\u20132008","volume":"207","author":"Okoroh","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mefs.2013.06.006","article-title":"Hospital-Based Prevalence of Polycystic Ovarian Syndrome among Omani Women","volume":"19","author":"Gowri","year":"2014","journal-title":"Middle East Fertil. Soc. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and Adverse Cardiovascular Risk Profile of Diagnosed Polycystic Ovary Syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5114\/aoms.2019.87112","article-title":"National and Regional Trends in the Prevalence of Polycystic Ovary Syndrome since 1990 within Europe: The Modeled Estimates from the Global Burden of Disease Study 2016","volume":"17","author":"Miazgowski","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.JIM.0000446834.90599.5d","article-title":"Epidemiology and Comorbidities of Polycystic Ovary Syndrome in an Indigent Population","volume":"62","author":"Sirmans","year":"2014","journal-title":"J. Investig. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"96351","DOI":"10.18632\/oncotarget.19180","article-title":"The Prevalence of Polycystic Ovary Syndrome in Reproductive-Aged Women of Different Ethnicity: A Systematic Review and Meta-Analysis","volume":"8","author":"Ding","year":"2017","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/wps.20611","article-title":"Innovations and Changes in the ICD-11 Classification of Mental, Behavioural and Neurodevelopmental Disorders","volume":"18","author":"Reed","year":"2019","journal-title":"World Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijmedinf.2006.11.005","article-title":"Reliability of Diagnoses Coding with ICD-10","volume":"77","author":"Stausberg","year":"2008","journal-title":"Int. J. Med. Inform."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1475-6773.2005.00444.x","article-title":"Measuring Diagnoses: ICD Code Accuracy","volume":"40","author":"Cook","year":"2005","journal-title":"Health Serv. Res."},{"key":"ref_28","first-page":"173","article-title":"Impact of Updated International Diagnostic Criteria for the Diagnosis of Polycystic Ovary Syndrome","volume":"4","author":"Kostroun","year":"2023","journal-title":"F S Rep."},{"key":"ref_29","first-page":"252","article-title":"Suitability of the National Health Care Surveys to Examine Behavioral Health Services Associated with Polycystic Ovary Syndrome","volume":"45","author":"Sanchez","year":"2018","journal-title":"J. Behav. Health Serv. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.fertnstert.2022.07.009","article-title":"The FIGO Ovulatory Disorders Classification System","volume":"118","author":"Munro","year":"2022","journal-title":"Fertil. Steril."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijgo.13125","article-title":"Prevalence of Polycystic Ovary Syndrome (PCOS) among Reproductive Age Women from Kashmir Valley: A Cross-Sectional Study","volume":"149","author":"Ganie","year":"2020","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_32","unstructured":"Boucher, H., Robin, G., Ribi\u00e8re, L., Martin, C., Espiard, S., and Catteau-Jonard, S. (2024). Annales d\u2019Endocrinologie (Paris), Elsevier Masson."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/21\/3\/354\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:14:30Z","timestamp":1760105670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/21\/3\/354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijerph21030354"],"URL":"https:\/\/doi.org\/10.3390\/ijerph21030354","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]}}}